Clinical outcomes associated with computed tomography-based body composition measures in lung transplantation: a systematic review.

Abstract

Computed tomography (CT) is gaining increased recognition in the assessment of body composition in lung transplant (LTx) candidates as a prognostic marker of post-transplant outcomes. This systematic review was conducted to describe the methodology of CT measures of body composition used in LTx patients and its association with post-transplant outcomes. Six databases were searched (inception-April 2020) for studies of adult LTx patients with thoracic or abdominal CT measures [muscle cross-sectional area (CSA) and/or adiposity]. Thirteen articles were included with 1911 LTx candidates, 58% males, mean age range (48-61years) and body mass index of 21.0-26.1kg/m2 . Several methods were utilized using thoracic or abdominal CT scans to assess skeletal muscle (n=11) and adiposity (n=4) at various anatomic locations (carina, thoracic, and lumbar vertebrae), differing muscle groups, and adipose tissue compartments. Low muscle mass was associated with adverse outcomes in 6/11 studies, including longer mechanical ventilation days (n=2), intensive care (n=2) and hospital stay (n=2), and mortality (n=4). Greater subcutaneous and mediastinal fat were associated with increased risk of primary graft dysfunction (n=2), but implications of adiposity on survival were variable across four studies. Further standardization of CT body composition assessments is needed to assess the prognostic utility of these measures on LTx outcomes.